Anthera Pharmaceuticals (ANTH), Theravance (THRX), Oracle (ORCL), FedEx (FDX), China Mobile (CHL) and Cabot (CBT) were upgraded or downgraded by analysts.
Theravance (THRX) initiated with a Buy at Brean Murray Target $24.
Oracle (ORCL) downgraded to Hold from Buy at Jefferies.Jefferies downgraded Oracle after its channel checks indicated the company's engineered systems strategy is facing challenges. The firm lowered its price target for shares to $32 from $35.
FedEx (FDX) initiated with a Neutral at Atlantic Equities Target $107.
China Mobile (CHL) upgraded to Overweight from Neutral at HSBC.
Cabot (CBT) upgraded to Buy from Hold at Jefferies.Jefferies upgraded Cabot citing favorable volume trends and raised its price target for shares to $50 from $44.
For the latest updates on the stock market, visit,
http://daytradingstock-blog.blogspot.com/